Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
Accurate prognostic information is desirable when counselling patients with brain metastases regarding their therapeutic options and life expectancy. Based on previous studies, we selected serum lactate dehydrogenase (LDH) as a promising factor on which we perform a pilot study investigating methodo...
Saved in:
Main Authors: | Carsten Nieder, Kirsten Marienhagen, Astrid Dalhaug, Jan Norum |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/609323 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Lactate Dehydrogenase Is a Sensitive Predictor of Systemic Complications of Acute Pancreatitis
by: Dong-Ni Huang, et al.
Published: (2022-01-01) -
Salivary Lactate Dehydrogenase Level: A Prognostic Biomarker for Oral Potentially Malignant Disorders
by: Jigna Shah, et al.
Published: (2024-11-01) -
Brain Metastases Research 1990–2010: Pattern of Citation and Systematic Review of Highly Cited Articles
by: Carsten Nieder, et al.
Published: (2012-01-01) -
Estimation of Salivary and Serum Lactate Dehydrogenase (LDH) Levels in Individuals with Oral Cancer, Oral Potentially Malignant Disorders, Tobacco Users, and Healthy Subjects – A Pilot Study
by: Mohithan Subramanian, et al.
Published: (2024-12-01) -
Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China
by: Yu L, et al.
Published: (2025-02-01)